Skip to main content
. 2018 Jul 13;19:133. doi: 10.1186/s12931-018-0836-6

Fig. 3.

Fig. 3

Time-course of bronchodilator activity of FF/VI. a: FEV1 change from baseline. b: PEF. Mean (a) FEV1 (L) after cessation of treatment and (b) Peak expiratory flow (L/min), during treatment and after cessation of treatment, plotted over time, for placebo (grey line) and FF/VI (black line). Error bars denote the standard error